为2型糖尿病设计的特殊医学用途配方食品核心结局集开发:研究方案
本研究以2型糖尿病(T2DM)为例,制定特殊医学用途配方食品(FSMP)临床试验的核心结局集(COS)。方案分三阶段:通过系统评价、监管文件和利益相关者定性访谈生成结局清单;开展至少2轮德尔菲调查,由患者、临床营养师、医师、COS研究者、期刊编辑、FSMP厂商和监管代表对结局重要性评分;召开共识会议确定最终COS。
要点
- COS为FSMP临床试验提供应测量和报告的最小结局集合。
- 方案遵循COS-STAP和COS-STAD,分三阶段制定FSMP-T2DM的COS。
- 德尔菲调查至少2轮,邀请多类利益相关者参与重要性评分。
核心结论
- 本研究旨在为2型糖尿病设计的特殊医学用途配方食品临床试验制定核心结局集。
研究设计与样本
- 研究方案分3个阶段,遵循COS-STAP和COS-STAD制定FSMP-T2DM的核心结局集。
- 第一阶段通过系统评价、监管文件和利益相关者定性访谈生成结局清单,并格式化为第一轮德尔菲调查问卷条目。
- 第二阶段开展至少2轮德尔菲调查,邀请患者、临床营养师、医师、COS研究者、期刊编辑、FSMP厂商和监管代表对各结局的重要性评分。
- 第三阶段召开面对面或在线共识会议,邀请关键利益相关者讨论并确定最终COS。
关键数值与推荐
- 核心结局集定义为应测量和报告的最小结局集合。
- 针对意外情况,研究准备了关于Likert量表选择、德尔菲调查轮次、评分组和共识定义的替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Chinese government stipulates all food for special medical purposes (FSMP) designed for specific diseases to be tested in clinical trials before approving it for registration. The process of developing core outcome sets (COSs), the minimum sets of outcomes supposed to be measured and reported, provides an economical and practical option for stakeholders to communicate and cooperate in conducting clinical trials as well as in reporting FSMP outcomes. This study uses type 2 diabetes mellitus (T2DM) as an example to develop COS for clinical trials of FSMP. METHODS: The COS for FSMP-T2DM will be divided into 3 phases and developed following COS-STAP and COS-STAD: (1) Generate a list of relevant outcomes identified from a systematic review, in which information sources will mainly include published studies, regulatory documentation, and qualitative interviews of stakeholders. The identified outcomes will be categorized using a conceptual framework and formatted into the first round of the Delphi survey questionnaire items. (2) At least 2 rounds of Delphi surveys will be performed among stakeholders to create the COS for FSMP-T2DM. Patients, clinical dietitians, physicians, COS researchers, journal editors, FSMP manufacturers, and regulatory representatives will be invited to score each outcome from aspects of importance. (3) Hold a face-to-face or online consensus meeting to refine the content of the COS for FSMP-T2DM. Key stakeholders will be invited to attend the meeting to discuss and agree on the final COS. DISCUSSION: We have prepared an alternative solution of the Likert scale selection, Delphi survey rounds, scoring group, and consensus definitions in case of an unexpected situation. TRIAL REGISTRATION: COMET (1547). Registered on March 23, 2020.
引用
- Mu D, Gong J, Wei Y, et al. Development of core outcome sets of Food for Special Medical Purposes designed for type 2 diabetes mellitus: a study protocol. Trials. 2023. PMID: 36959627. doi:10.1186/s13063-023-07214-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。